The genomics industry is involved in designing high-quality treatment procedures for life-threatening diseases like cancer, using genetic components of living beings. Demand for genomics suppliers increases every day, with more people in an increasingly aging population being diagnosed with serious illnesses. During the second half of 2021, genomics-related deals accounted for 5.9% of all deals taking place in the pharmaceutical sector.
Despite high operational costs and logistic hindrances, genomics suppliers continue to register solid revenues and cash flows thanks to the surging demand. The rapid advancements in medical technology and research and development should keep driving the industry’s performance. According to Reports and Data, the global genomics market is expected to grow at a CAGR of 19% by 2030.
